Wednesday, May 17 2023
09:00 AM – 09:45 AM PT
Panelist
Claire Henchcliffe, MD DPhil. University of California, Irvine, Irvine, CA
Disclosures: C. Henchcliffe: 1; Commercial Interest i.e. Company X; Asklepios Biopharmaceutical Inc. 1; What was received? i.e. Honorarium; honorarium. 1; For what role? i.e. Speaker; Advisory Board member. 2; Commercial Interest i.e. Company X; Bayer. 2; What was received? i.e. Honorarium; Honorarium. 2; For what role? i.e. Speaker; Parkinson's Disease Standing Expert Panel. 3; Commercial Interest i.e. Company X; UCLA. 3; What was received? i.e. Honorarium; Honorarium. 3; For what role? i.e. Speaker; Grand Rounds. 4; Commercial Interest i.e. Company X; Aspen Neurosciences. 4; What was received? i.e. Honorarium; Travel payment. 4; For what role? i.e. Speaker; Consulting. 5; Commercial Interest i.e. Company X; Axent Neurosciences. 5; What was received? i.e. Honorarium; Stock. 5; For what role? i.e. Speaker; Advisory Board. 6; Commercial Interest i.e. Company X; NIH/NCATS. 6; What was received? i.e. Honorarium; Honorarium. 6; For what role? i.e. Speaker; Grant review.